• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂蛋白(a)和胆固醇水平具有协同作用,载脂蛋白A-I对中年男性原发性急性心肌梗死的发生具有保护作用。一项来自瑞典的病例对照研究。

Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A-I is protective for the incidence of primary acute myocardial infarction in middle-aged males. An incident case-control study from Sweden.

作者信息

Dahlén G H, Weinehall L, Stenlund H, Jansson J H, Hallmans G, Huhtasaari F, Wall S

机构信息

Department of Clinical Chemistry, Umeå University, Sweden.

出版信息

J Intern Med. 1998 Nov;244(5):425-30. doi: 10.1046/j.1365-2796.1998.00422.x.

DOI:10.1046/j.1365-2796.1998.00422.x
PMID:9845859
Abstract

OBJECTIVE

To further establish the importance of total plasma apolipoprotein A-I and lipoprotein(a) in the prediction of primary acute myocardial infarction (AMI) in men.

DESIGN

An incident case-control study.

SETTING

The study was nested within the Västerbotten Intervention Program (VIP) and the Northern Sweden MONICA cohorts.

SUBJECTS

A total of 62 male AMI cases and 124 matched controls, randomly selected from the study cohorts.

RESULTS

In multivariate logistic regression, significant odds ratios (OR) were found for Lp(a) above 200 mg L-1, apo A-I below the mean value (1136 mg L-1) and total cholesterol (TC) above 7.8 mmol L-1. TC interacted significantly with Lp(a); for Lp(a) above 200 mg L-1 and TC below 6.5 mmol L-1, OR = 5.6; for Lp(a) above 200 mg L-1 and TC above 6.5 mmol L-1, OR = 12.6. To evaluate the potential effect of reducing high levels of Lp(a) or TC on the incidence of AMI in males, the attributable risk percentage (ARP) was calculated when interaction between the two variables was present. ARP is 31% for Lp(a) and 21% for TC, implying that 31% of the cases are due to high Lp(a) and 21% of the cases are due to high TC levels.

CONCLUSIONS

In the Swedish male population, total apo A-I in plasma is a protective factor and a plasma Lp(a) level above 200 mg L-1 is a risk factor for AMI in males. A TC level above 6.5 mmol L-1 increased the risk of AMI if the Lp(a) level was above 200 mg L-1, suggesting Lp(a) to be useful in identifying high risk individuals needed to be treated.

摘要

目的

进一步确立血浆总载脂蛋白A-I和脂蛋白(a)在预测男性原发性急性心肌梗死(AMI)中的重要性。

设计

一项病例对照研究。

地点

该研究嵌套于韦斯特博滕干预项目(VIP)和瑞典北部莫尼卡队列研究中。

研究对象

从研究队列中随机选取62例男性AMI病例和124例匹配对照。

结果

在多因素逻辑回归分析中,发现脂蛋白(a)高于200 mg/L、载脂蛋白A-I低于均值(1136 mg/L)以及总胆固醇(TC)高于7.8 mmol/L时,优势比(OR)有显著意义。TC与脂蛋白(a)存在显著交互作用;对于脂蛋白(a)高于200 mg/L且TC低于6.5 mmol/L,OR = 5.6;对于脂蛋白(a)高于200 mg/L且TC高于6.5 mmol/L,OR = 12.6。为评估降低高水平脂蛋白(a)或TC对男性AMI发病率的潜在影响,在两个变量存在交互作用时计算了归因风险百分比(ARP)。脂蛋白(a)的ARP为31%,TC的ARP为21%,这意味着31%的病例归因于高脂蛋白(a),21%的病例归因于高TC水平。

结论

在瑞典男性人群中,血浆总载脂蛋白A-I是一个保护因素,血浆脂蛋白(a)水平高于200 mg/L是男性AMI的一个危险因素。如果脂蛋白(a)水平高于200 mg/L,TC水平高于6.5 mmol/L会增加AMI风险,这表明脂蛋白(a)有助于识别需要治疗的高危个体。

相似文献

1
Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A-I is protective for the incidence of primary acute myocardial infarction in middle-aged males. An incident case-control study from Sweden.脂蛋白(a)和胆固醇水平具有协同作用,载脂蛋白A-I对中年男性原发性急性心肌梗死的发生具有保护作用。一项来自瑞典的病例对照研究。
J Intern Med. 1998 Nov;244(5):425-30. doi: 10.1046/j.1365-2796.1998.00422.x.
2
Lp(a) lipoprotein is a major risk factor for cardiovascular disease: pathogenic mechanisms and clinical significance.脂蛋白(a)是心血管疾病的主要危险因素:致病机制及临床意义。
Clin Genet. 1997 Nov;52(5):272-80. doi: 10.1111/j.1399-0004.1997.tb04344.x.
3
[Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].[载脂蛋白(a)基因五核苷酸重复序列多态性与中国心肌梗死和脑梗死患者血浆脂蛋白(a)水平的关系]
Zhonghua Yi Xue Za Zhi. 2002 Oct 25;82(20):1396-400.
4
Perceived health modifies the effect of biomedical risk factors in the prediction of acute myocardial infarction. An incident case-control study from northern Sweden.感知健康在急性心肌梗死预测中会改变生物医学风险因素的作用。瑞典北部的一项病例对照研究。
J Intern Med. 1998 Feb;243(2):99-107. doi: 10.1046/j.1365-2796.1998.00201.x.
5
Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.有早发心肌梗死家族史的健康年轻受试者的脂蛋白(a)水平升高。
Nutr Metab Cardiovasc Dis. 2008 Sep;18(7):492-6. doi: 10.1016/j.numecd.2007.03.006. Epub 2007 Oct 24.
6
Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction.纤溶、脂蛋白与瘦素之间的相互作用与首次心肌梗死有关。
Eur J Cardiovasc Prev Rehabil. 2004 Feb;11(1):33-40. doi: 10.1097/01.hjr.0000116824.84388.a2.
7
Lipoprotein(a) concentration does not differ between sexes in healthy offspring of patients with premature myocardial infarction.脂蛋白(a)浓度在早发性心肌梗死患者健康后代的男女性别之间无差异。
J Cardiovasc Med (Hagerstown). 2011 Jul;12(7):482-6. doi: 10.2459/JCM.0b013e328346d367.
8
A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.在斯坦福五城市项目参与者中开展的一项关于脂蛋白(a)水平、载脂蛋白(a)大小与冠心病风险的前瞻性病例对照研究。
Arterioscler Thromb Vasc Biol. 1997 Feb;17(2):239-45. doi: 10.1161/01.atv.17.2.239.
9
Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels.脂蛋白(a)水平升高与正常低密度脂蛋白胆固醇水平的急性心肌梗死患者有关。
Biosci Rep. 2019 Apr 5;39(4). doi: 10.1042/BSR20182096. Print 2019 Apr 30.
10
Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia.脂蛋白(a)作为普通高胆固醇血症患者心肌梗死的独立危险因素。
J Clin Pathol. 1993 Mar;46(3):267-70. doi: 10.1136/jcp.46.3.267.

引用本文的文献

1
The levels of serum lipoprotein(a) on clinical outcomes in Chinese hospitalized patients with cardiovascular diseases.血清脂蛋白(a)水平与中国心血管疾病住院患者临床结局的关系。
Eur J Med Res. 2024 Aug 17;29(1):421. doi: 10.1186/s40001-024-01957-7.
2
Lipoprotein(a) Lowering-From Lipoprotein Apheresis to Antisense Oligonucleotide Approach.降低脂蛋白(a)——从脂蛋白分离术到反义寡核苷酸疗法
J Clin Med. 2020 Jul 3;9(7):2103. doi: 10.3390/jcm9072103.
3
Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians.
脂蛋白(a):印度年轻人群中未被充分认识的恶性冠状动脉疾病遗传危险因素。
Indian Heart J. 2019 May-Jun;71(3):184-198. doi: 10.1016/j.ihj.2019.04.007. Epub 2019 May 2.
4
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.脂蛋白(a)作为心血管疾病的一个病因:来自流行病学、遗传学和生物学的见解
J Lipid Res. 2016 Nov;57(11):1953-1975. doi: 10.1194/jlr.R071233. Epub 2016 Sep 27.
5
Relationship between Lipoprotein(a) and Thyroid Hormones in Hypothyroid Patients.甲状腺功能减退患者中脂蛋白(a)与甲状腺激素的关系。
J Clin Diagn Res. 2014 Feb;8(2):37-9. doi: 10.7860/JCDR/2014/7817.4001. Epub 2014 Feb 3.
6
Lipoprotein(a) in cardiovascular diseases.脂蛋白(a)与心血管疾病。
Biomed Res Int. 2013;2013:650989. doi: 10.1155/2013/650989. Epub 2012 Dec 30.
7
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.脂蛋白(a)浓度与冠心病、中风及非血管性死亡风险
JAMA. 2009 Jul 22;302(4):412-23. doi: 10.1001/jama.2009.1063.
8
Lipoprotein(a) and coronary heart disease risk.脂蛋白(a)与冠心病风险
Curr Cardiol Rep. 1999 Jul;1(2):105-11. doi: 10.1007/s11886-999-0067-z.